NO163656C - Fremgangsmaate for in vitro diagnostisering av bakterieinfeksjoner fremkalt av pneumokokker samt forbindelser for anvendelse ved fremgangsmaaten. - Google Patents

Fremgangsmaate for in vitro diagnostisering av bakterieinfeksjoner fremkalt av pneumokokker samt forbindelser for anvendelse ved fremgangsmaaten.

Info

Publication number
NO163656C
NO163656C NO841135A NO841135A NO163656C NO 163656 C NO163656 C NO 163656C NO 841135 A NO841135 A NO 841135A NO 841135 A NO841135 A NO 841135A NO 163656 C NO163656 C NO 163656C
Authority
NO
Norway
Prior art keywords
procedure
residue
infections caused
hydrogen
compounds
Prior art date
Application number
NO841135A
Other languages
English (en)
Norwegian (no)
Other versions
NO841135L (no
NO163656B (no
Inventor
Bengt Andersson
Hakon Leffler
Goeran Magnusson
Catharina Svanborg-Eden
Original Assignee
Svanborg Eden Catharina
Bengt Andersson
Hakon Leffler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Svanborg Eden Catharina, Bengt Andersson, Hakon Leffler filed Critical Svanborg Eden Catharina
Publication of NO841135L publication Critical patent/NO841135L/no
Publication of NO163656B publication Critical patent/NO163656B/no
Publication of NO163656C publication Critical patent/NO163656C/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fats And Perfumes (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Socks And Pantyhose (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO841135A 1983-03-23 1984-03-22 Fremgangsmaate for in vitro diagnostisering av bakterieinfeksjoner fremkalt av pneumokokker samt forbindelser for anvendelse ved fremgangsmaaten. NO163656C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8301609A SE8301609D0 (sv) 1983-03-23 1983-03-23 Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling

Publications (3)

Publication Number Publication Date
NO841135L NO841135L (no) 1984-09-24
NO163656B NO163656B (no) 1990-03-19
NO163656C true NO163656C (no) 1990-06-27

Family

ID=20350499

Family Applications (1)

Application Number Title Priority Date Filing Date
NO841135A NO163656C (no) 1983-03-23 1984-03-22 Fremgangsmaate for in vitro diagnostisering av bakterieinfeksjoner fremkalt av pneumokokker samt forbindelser for anvendelse ved fremgangsmaaten.

Country Status (10)

Country Link
EP (1) EP0126043B1 (fr)
JP (1) JPS59176300A (fr)
AT (1) ATE47595T1 (fr)
AU (1) AU566286B2 (fr)
DE (1) DE3480288D1 (fr)
DK (1) DK160484A (fr)
FI (1) FI841161A (fr)
IL (1) IL71239A (fr)
NO (1) NO163656C (fr)
SE (1) SE8301609D0 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2564468B1 (fr) * 1984-05-16 1994-12-23 Choay Sa Nouveaux oligosaccharides, leur preparation par voie de synthese et leurs applications biologiques
DK17685D0 (da) * 1985-01-14 1985-01-14 Hans Goeran Magnusson Glycosidderivater
SE8501613D0 (sv) * 1985-04-01 1985-04-01 Bio Carb Ab Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
EP0287029A2 (fr) * 1987-04-14 1988-10-19 Pulverer, Gerhard, Prof. Dr.Dr.h.c. Utilisation de monosaccharides et/ou de glycoconjugués contenant ces monosaccharides pour le traitement des infections causées par des agents pathogènes
SE463314B (sv) * 1989-03-01 1990-11-05 Biocarb Ab Sampolymerer av en n-acylerad glykosylamin och en amid, n-akryloyl-eller metakryloylglykosylaminer samt foerfarande foer framstaellning av dessa
CA2095642C (fr) * 1990-08-02 1999-12-14 Howard C. Krivan Recepteurs de microorganismes pathogenes ou opportunistes
US5718909A (en) * 1991-02-18 1998-02-17 Medscand Ab Sheet containing carbohydrate derivative for removal of E. coli
SE469256B (sv) * 1991-02-18 1993-06-14 Medscand Ab Rengoeringsprodukt
EP0563795B1 (fr) * 1992-03-31 1998-07-22 Dai Nippon Printing Co., Ltd. Electrode avec enzyme immobilisée, composition pour sa préparation et enzyme électroconductrice
US5401723A (en) * 1992-12-02 1995-03-28 Colgate-Palmolive Company Glycoconjugate inhibition of Streptococcus pyrogenes adhesion
US5514665A (en) * 1993-12-30 1996-05-07 University Of British Columbia Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
US5665561A (en) * 1994-06-06 1997-09-09 The Rockefeller University Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
US7144989B2 (en) 2002-03-25 2006-12-05 Albert Einstein College Of Medicine Of Yeshiva University Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof
US6737524B2 (en) 2002-03-25 2004-05-18 Paul K. Smith Activated polyethylene glycol compounds
ATE361101T1 (de) 2004-08-24 2007-05-15 Nutricia Nv Nahrungszusammensetzung die unverdauliche oligosaccharide enthält

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324887A (en) * 1978-08-16 1982-04-13 President And Fellows Of Harvard College Type II group B Streptococci polysaccharide
SE8000658L (sv) * 1980-01-28 1981-07-29 Sigfried Edvin Svensson Isolering av kolhydrater ur cellvevnad
SE8001748L (sv) * 1980-03-05 1981-09-06 Kaellenius Gunilla Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
US4464360A (en) * 1980-05-09 1984-08-07 Hakon Leffler Glycosphingalipids for inhibiting bacterial adherence
AU561066B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Antibacterial composition containing an oligosaccharide
DK131083A (da) * 1982-03-23 1983-09-24 Svenska Sockerfabriks Ab Fremgangsmaade til fremstilling af terapeutiske eller diagnostiske praeparater

Also Published As

Publication number Publication date
IL71239A (en) 1993-05-13
NO841135L (no) 1984-09-24
FI841161A (fi) 1984-09-24
AU566286B2 (en) 1987-10-15
DE3480288D1 (en) 1989-11-30
FI841161A0 (fi) 1984-03-22
EP0126043B1 (fr) 1989-10-25
NO163656B (no) 1990-03-19
AU2587184A (en) 1984-09-27
IL71239A0 (en) 1984-06-29
ATE47595T1 (de) 1989-11-15
EP0126043A1 (fr) 1984-11-21
DK160484A (da) 1984-09-24
SE8301609D0 (sv) 1983-03-23
JPS59176300A (ja) 1984-10-05
DK160484D0 (da) 1984-03-20

Similar Documents

Publication Publication Date Title
NO163656C (no) Fremgangsmaate for in vitro diagnostisering av bakterieinfeksjoner fremkalt av pneumokokker samt forbindelser for anvendelse ved fremgangsmaaten.
ATE21699T1 (de) Verfahren zur herstellung von 2-penemverbindungen.
DE69301897D1 (de) Erythromycinderivate, ihr Verfahren zur Herstellung und ihre Verwendung als Arzneimitteln
ATE139783T1 (de) Azasteroide zur behandlung prostatischer hypertrophie, ihre herstellung und verwendung
DE3881246D1 (de) Durch benzhydryl n-substituierte heterocyclische derivate, ihre herstellung und ihre verwendung.
DK633088A (da) Kollagenaseinhibitorer
ATE50774T1 (de) Neue fructosyltsansferase und verfahren zur herstellung von fructosyl-disacchariden, sowie eine neue halosaccharose.
BG101402A (en) Apoliprotein-b synthesis inhibitors
ATE59646T1 (de) 4-brommethyl-5-methyl-1,3-dioxolen-2 -on und verfahren zu seiner herstellung.
DE3853538D1 (de) Glykosidester und verfahren zur enzymatischen herstellung.
DE68924237D1 (de) Verfahren zur Herstellung von Verbindungen zur Behandlung der gutartigen Prostatahypertrophie.
ATE67199T1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
DK0407891T3 (da) 3-methoximinopropionsyreestere og fungicider indeholdende disse
DE59207425D1 (de) Imidazolylmethyl-Pyridine
DE3889772D1 (de) Verfahren zur Herstellung von 3,3-Diarylacrylsäureamiden.
ATE69448T1 (de) Chinolincarbonsaeure-derivate, diese enthaltende zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten.
SE8406626D0 (sv) Forening och komposition for terapeutisk eller diagnostisk anvendning jemte anvendning av sadan forening och komposition for terapeutisk behandling och isolering av shigatoxin
ES2054829T3 (es) Antibioticos del grupo mureidomicina, su preparacion y su empleo.
DE69015220D1 (de) Glycocyamidin-Derivate.
HU905000D0 (en) Process for producing compounds suitable for treatment of gastric ulcer
TH2200EX (th) แอมมิดีนที่เป็นสารใหม่
DK41190A (da) Hidtil ukendte organiske forbindelser og fremgangsmaade til fremstilling deraf
TH2200A (th) แอมมิดีนที่เป็นสารใหม่